Joanne Edwards

14.7k total citations · 2 hit papers
264 papers, 9.1k citations indexed

About

Joanne Edwards is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Joanne Edwards has authored 264 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Oncology, 93 papers in Molecular Biology and 76 papers in Cancer Research. Recurrent topics in Joanne Edwards's work include Prostate Cancer Treatment and Research (43 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Colorectal Cancer Surgical Treatments (28 papers). Joanne Edwards is often cited by papers focused on Prostate Cancer Treatment and Research (43 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Colorectal Cancer Surgical Treatments (28 papers). Joanne Edwards collaborates with scholars based in United Kingdom, United States and Thailand. Joanne Edwards's co-authors include John M.S. Bartlett, Donald C. McMillan, Paul G. Horgan, James J. Going, N. Sarath Krishna, Antonia K. Roseweir, Clare Orange, Ken Grigor, Beatrix Elsberger and Nigel J. Pyne and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Joanne Edwards

252 papers receiving 8.9k citations

Hit Papers

A Novel Androgen Receptor... 2009 2026 2014 2020 2009 2012 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Joanne Edwards 4.6k 3.0k 3.0k 2.3k 873 264 9.1k
Karen E. Knudsen 6.3k 1.4× 4.1k 1.4× 4.0k 1.3× 2.5k 1.1× 1.2k 1.4× 169 11.1k
Natasha Kyprianou 3.9k 0.9× 2.7k 0.9× 2.0k 0.7× 1.7k 0.7× 605 0.7× 135 7.5k
Ilsa M. Coleman 3.8k 0.8× 4.0k 1.3× 2.2k 0.7× 2.2k 1.0× 725 0.8× 111 7.8k
Ladan Fazli 6.4k 1.4× 4.4k 1.4× 2.7k 0.9× 2.9k 1.2× 907 1.0× 250 11.2k
Paul N. Span 5.1k 1.1× 1.3k 0.4× 2.5k 0.8× 3.1k 1.3× 869 1.0× 233 9.7k
Samuel R. Denmeade 4.4k 1.0× 4.3k 1.4× 2.6k 0.9× 2.2k 0.9× 707 0.8× 223 9.8k
Haruhiko Sugimura 7.2k 1.6× 2.1k 0.7× 3.0k 1.0× 2.6k 1.1× 1.2k 1.4× 405 12.4k
Donna M. Peehl 5.6k 1.2× 3.5k 1.1× 2.3k 0.8× 2.2k 0.9× 1.7k 2.0× 211 11.8k
Hui‐Kuan Lin 7.6k 1.7× 1.8k 0.6× 2.3k 0.7× 2.4k 1.0× 1.0k 1.2× 120 10.7k
Christopher P. Evans 5.1k 1.1× 4.9k 1.6× 1.8k 0.6× 3.6k 1.6× 674 0.8× 250 10.3k

Countries citing papers authored by Joanne Edwards

Since Specialization
Citations

This map shows the geographic impact of Joanne Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Edwards more than expected).

Fields of papers citing papers by Joanne Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Edwards. The network helps show where Joanne Edwards may publish in the future.

Co-authorship network of co-authors of Joanne Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Edwards. A scholar is included among the top collaborators of Joanne Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Edwards. Joanne Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGovern, Josh, et al.. (2024). The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 199. 104378–104378. 6 indexed citations
2.
Knight, Katrina, Christopher Bigley, Kathryn A.F. Pennel, et al.. (2024). The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer. The Journal of Pathology Clinical Research. 10(4). e12385–e12385. 2 indexed citations
3.
Moreno, Rita, Kira Allmeroth, Jean A. Quinn, et al.. (2023). Dual inhibition of HSF1 and DYRK2 impedes cancer progression. Bioscience Reports. 43(1). 10 indexed citations
4.
Brouwer, Nelleke P.M., Amjad Khan, John‐Melle Bokhorst, et al.. (2023). The Complexity of Shapes: How the Circularity of Tumor Nodules Affects Prognosis in Colorectal Cancer. Modern Pathology. 37(1). 100376–100376. 3 indexed citations
6.
Pennel, Kathryn A.F., Jean A. Quinn, Colin Nixon, et al.. (2022). CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer. The Journal of Pathology Clinical Research. 8(6). 509–520. 7 indexed citations
7.
Mansouri, David, Stephen T. McSorley, James H. Park, et al.. (2021). The inflammatory microenvironment in screen-detected premaligant adenomatous polyps: early results from the integrated technologies for improved polyp surveillance (INCISE) project. European Journal of Gastroenterology & Hepatology. 33(7). 983–989. 2 indexed citations
8.
Quinn, Jean A., et al.. (2021). Systematic review of tumour budding and association with common mutations in patients with colorectal cancer. Critical Reviews in Oncology/Hematology. 167. 103490–103490. 7 indexed citations
9.
Rooney, Nicholas, Susan Mason, Laura McDonald, et al.. (2020). RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome. Cancer Research. 80(11). 2325–2339. 29 indexed citations
10.
Roseweir, Antonia K., James H. Park, Sanne ten Hoorn, et al.. (2020). Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer. The Journal of Pathology Clinical Research. 6(4). 283–296. 12 indexed citations
11.
Roseweir, Antonia K., Kathryn A.F. Pennel, Hester C. van Wyk, et al.. (2020). The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer. British Journal of Cancer. 124(4). 786–796. 14 indexed citations
13.
Campbell, Kirsteen J., Sandeep Dhayade, Nicola Ferrari, et al.. (2018). MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease. 9(2). 19–19. 144 indexed citations
14.
Roseweir, Antonia K., et al.. (2018). The role of gamma delta T lymphocytes in breast cancer: a review. Translational research. 203. 88–96. 46 indexed citations
15.
Park, James H., Donald C. McMillan, Jean A. Quinn, et al.. (2016). Signal Transduction and Activator of Transcription-3 (STAT3) in Patients with Colorectal Cancer: Associations with the Phenotypic Features of the Tumor and Host. Clinical Cancer Research. 23(7). 1698–1709. 37 indexed citations
17.
Mardilovich, Katerina, Mads Gabrielsen, Lynn McGarry, et al.. (2014). Elevated LIM Kinase 1 in Nonmetastatic Prostate Cancer Reflects Its Role in Facilitating Androgen Receptor Nuclear Translocation. Molecular Cancer Therapeutics. 14(1). 246–258. 34 indexed citations
18.
Hu, Rong, Changxue Lu, Elahe A. Mostaghel, et al.. (2012). Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer. Cancer Research. 72(14). 3457–3462. 451 indexed citations breakdown →
19.
Guo, Zhiyong, Xi Yang, Feng Sun, et al.. (2009). A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth. Cancer Research. 69(6). 2305–2313. 698 indexed citations breakdown →
20.
McGlynn, Liane M., Tove Kirkegaard, Joanne Edwards, et al.. (2009). Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients. Clinical Cancer Research. 15(4). 1487–1495. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026